Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2000-9-1
pubmed:abstractText
To determine the effect of polymorphic variations in the tumor necrosis factor alpha (TNFalpha) and lymphotoxin alpha (LTalpha) genes on the predisposition to myeloma and the effect of these polymorphisms on response to treatment and overall survival.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2843-51
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10920132-Adult, pubmed-meshheading:10920132-Aged, pubmed-meshheading:10920132-Antineoplastic Agents, pubmed-meshheading:10920132-Case-Control Studies, pubmed-meshheading:10920132-Disease Progression, pubmed-meshheading:10920132-Disease-Free Survival, pubmed-meshheading:10920132-Female, pubmed-meshheading:10920132-Genetic Predisposition to Disease, pubmed-meshheading:10920132-Haplotypes, pubmed-meshheading:10920132-Humans, pubmed-meshheading:10920132-Lymphotoxin-alpha, pubmed-meshheading:10920132-Male, pubmed-meshheading:10920132-Middle Aged, pubmed-meshheading:10920132-Multiple Myeloma, pubmed-meshheading:10920132-Polymorphism, Genetic, pubmed-meshheading:10920132-Prognosis, pubmed-meshheading:10920132-Risk Factors, pubmed-meshheading:10920132-Survival Analysis, pubmed-meshheading:10920132-Tumor Markers, Biological, pubmed-meshheading:10920132-Tumor Necrosis Factor-alpha
pubmed:year
2000
pubmed:articleTitle
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment.
pubmed:affiliation
Department of Haematology, Leeds General Infirmary and University of Leeds, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't